Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors
- PMID: 19682910
- DOI: 10.1016/j.bmc.2009.07.033
Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors
Abstract
A novel series of 2-thiocarbamoyl-2,3,4,5,6,7-hexahydro-1H-indazole and 2-substituted thiocarbamoyl-3,3a,4,5,6,7-hexahydro-2H-indazoles derivatives were synthesized and investigated for the ability to inhibit the activity of the A and B isoforms of monoamine oxidase (MAO). The target molecules were identified on the basis of satisfactory analytical and spectra data (IR, (1)H NMR, (13)C NMR, (2)D NMR, DEPT, EI-MASS techniques and elemental analysis). Synthesized compounds showed high activity against both the MAO-A (compounds 1d, 1e, 2c, 2d, 2e) and the MAO-B (compounds 1a, 1b, 1c, 2a, 2b) isoforms. In the discussion of the results, the influence of the structure on the biological activity of the prepared compounds was delineated. It was suggested that non-substituted and N-methyl/ethyl bearing compounds (except 2c) increased the inhibitory effect and selectivity toward MAO-B. The rest of the compounds, carrying N-allyl and N-phenyl, appeared to select the MAO-A isoform. The inhibition profile was found to be competitive and reversible for all compounds. A series of experimentally tested (1a-2e) compounds was docked computationally to the active site of the MAO-A and MAO-B isoenzyme. The autodock 4.01 program was employed to perform automated molecular docking. In order to see the detailed interactions of the docked poses of the model inhibitors compounds 1a, 1d, 1e and 2e were chosen because of their ability to reversibly inhibit the MAO-B and MAO-A and the availability of experimental inhibition data. The differences in the intermolecular hydrophobic and H-bonding of ligands to the active site of each MAO isoform were correlated to their biological data. Observation of the docked positions of these ligands revealed interactions with many residues previously reported to have an effect on the inhibition of the enzyme. Excellent to good correlations between the calculated and experimental K(i) values were obtained. In the docking of the MAO-A complex, the trans configuration of compound 1e made various very close interactions with the residues lining the active site cavity these interactions were much better than those of the other compounds tested in this study. This tight binding observation may be responsible for the nanomolar inhibition of form of MAOA. However, it binds slightly weaker (experimental K(i)=1.23 microM) to MAO-B than to MAO-A (experimental K(i)=4.22 nM).
Similar articles
-
New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.Bioorg Med Chem. 2009 Jan 15;17(2):675-89. doi: 10.1016/j.bmc.2008.11.068. Epub 2008 Dec 3. Bioorg Med Chem. 2009. PMID: 19091581
-
Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.J Med Chem. 2005 Apr 7;48(7):2407-19. doi: 10.1021/jm0493109. J Med Chem. 2005. PMID: 15801832
-
Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.Bioorg Med Chem Lett. 2005 Oct 15;15(20):4438-46. doi: 10.1016/j.bmcl.2005.07.043. Bioorg Med Chem Lett. 2005. PMID: 16137882
-
[Use of selective inhibitors for computer modeling of the monoamine oxidase active site].Vopr Med Khim. 1997 Nov-Dec;43(6):527-36. Vopr Med Khim. 1997. PMID: 9503570 Review. Russian.
-
Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.Neurotoxicology. 2004 Jan;25(1-2):243-50. doi: 10.1016/S0161-813X(03)00103-7. Neurotoxicology. 2004. PMID: 14697899 Review.
Cited by
-
Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors.Molecules. 2018 Jan 8;23(1):113. doi: 10.3390/molecules23010113. Molecules. 2018. PMID: 29316677 Free PMC article.
-
Enantioselective Interactions of Anti-Infective 8-Aminoquinoline Therapeutics with Human Monoamine Oxidases A and B.Pharmaceuticals (Basel). 2021 Apr 22;14(5):398. doi: 10.3390/ph14050398. Pharmaceuticals (Basel). 2021. PMID: 33922294 Free PMC article.
-
Design, Synthesis, and Biological Effect Studies of Novel Benzofuran-Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors.ACS Omega. 2024 Feb 29;9(10):11388-11397. doi: 10.1021/acsomega.3c07703. eCollection 2024 Mar 12. ACS Omega. 2024. PMID: 38496951 Free PMC article.
-
Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol.Molecules. 2015 Apr 23;20(5):7454-73. doi: 10.3390/molecules20057454. Molecules. 2015. PMID: 25915461 Free PMC article.
-
Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors.J Enzyme Inhib Med Chem. 2020 Dec;35(1):1422-1432. doi: 10.1080/14756366.2020.1784892. J Enzyme Inhib Med Chem. 2020. PMID: 32602377 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information